| 翻訳と辞書 |
Renovo plc
Renovo Group plc () is a biopharmaceutical company, which was founded in 1998 and is headquartered in Manchester, United Kingdom. It works in the discovery and development of drugs to reduce scarring, improve wound healing and enhance tissue regeneration.〔(London Regenerative Medicine Network – January 2007 Meeting )〕 Renovo does not currently have any marketed products. It aims "to be first to market with a scar prevention pharmaceutical drug in the US and Europe"〔http://www.renovo.com〕 in approximately 2014. As of 2011, it employs 10 people, although it once employed over 100.〔(Pharma Times Just 10% of workforce left at Renovo after Juvista failure (4 March 2011) ). Pharmatimes.com.〕
Renovo is listed on the London Stock Exchange and is a constituent of the FTSE Fledgling Index.
==Products==
Renovo does not currently have any marketed products. Its development pipeline currently includes one drug in phase III clinical development, two drugs in phase II clinical development, and numerous pre-clinical candidates.〔(Renovo – Products )〕
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Renovo plc」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|